NASDAQ:APLS

Apellis Pharmaceuticals Stock News

etoro logo Buy APLS
*Your capital is at risk
$41.03
+0 (+0%)
At Close: Jun 03, 2026
WALTHAM, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced its third quart
WALTHAM, Mass. and STOCKHOLM, Sweden, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announced a strat
Strs Ohio lessened its position in shares of Apellis Pharmaceuticals Inc (NASDAQ:APLS) by 68.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commissi
Apellis Pharmaceuticals Inc (NASDAQ:APLS) – Wedbush lifted their Q3 2020 earnings per share estimates for shares of Apellis Pharmaceuticals in a research report issued to clients and investors on Mo
Lea Michele was spotted in the $140 sneakers.
According to the company, claims under various regulatory orders stand at Rs 235 billion (50% approved; Rs 60 billion received so far). Subsequent to approval from Board and shareholders, the company
WALTHAM, Mass., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced that the company a

Alexa Live Was Its Biggest Developer Launch, Ever

12:00am, Thursday, 06'th Aug 2020
#1-Ranked Industry Analyst Patrick Moorhead takes a look at Alexa Live, Amazon plotted out a course for the future of Alexa, unveiling a whole slew of new capabilities, APIs, and tools for the intelli
Sebi found that during the UPSI period, i.e during July  22, 2008 to March 3, 2009, Top Class Capital Markets traded in APL shares in violation of Prohibition of Insider Trading regulations. In the
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Apellis Pharmaceuticals
* New Drug Application (NDA) and Marketing Authorization Application (MAA) Submissions for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH) Planned for the Second Half of 2020 * Phase 3 DER
The proposed transaction relates to the acquisition of 49% of the total equity share capital of OPGC by APL (Proposed Combination).
New campaign urges Irish public to keep eye care appointments and be vigilant for signs of age-related macular degeneration
The Competition Commission of India (CCI) on Thursday approved the proposed acquisition of 49 per cent of the total equity share capital of Odisha Power Generation Corporation Limited (OPGC) by Adani
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE